GlassScriptPhysician profile
Eric Joseph Thomassee
NPI 1053515544
$148,658.89
in general payments reported to CMS, 2019-2025
16 companies · $39K in 2025
The $39K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $16K · 2021: $7,972 · 2022: $11K · 2023: $25K · 2024: $32K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $79K · Travel and Lodging: $10K · Food and Beverage: $6,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $79,112.50 |
| Travel and Lodging | $10,075.92 |
| Food and Beverage | $6,782.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $143,928.79 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $1,976.10 | 2019-2024 | Mitraclip, Diamondback Coronary |
| Boston Scientific Corporation | $1,160.39 | 2019-2025 | Watchman Flx, Watchman Access System, Eluvia |
| Abiomed | $856.69 | 2019-2025 | Impella |
| Amgen INC. | $200.77 | 2024-2025 | Repatha, Repatha |
| W. L. Gore & Associates, INC. | $98.34 | 2024 | Gore Cardioform Septal Occluder |
| Philips North America LLC | $85.62 | 2022 | |
| Welch Allyn | $61.14 | 2021 | |
| Baxter Healthcare | $61.14 | 2022 | |
| Medtronic, INC. | $57.89 | 2023-2024 | Onyx Frontier, Protege Rx |
| Scpharmaceuticals INC. | $45.46 | 2025 | |
| Novartis Pharmaceuticals Corporation | $39.00 | 2025 | |
| Merck Sharp & Dohme LLC | $29.14 | 2025 | Verquvo |
| Cardiovascular Systems INC. | $26.49 | 2022 | |
| Lilly USA, LLC | $19.75 | 2025 | Zepbound |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Thomassee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.